| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015097521 | 2015-05-12 | ||
| PCT/JP2016/063989WO2016181990A1 (en) | 2015-05-12 | 2016-05-11 | Crystals of azabicyclic compound |
| Publication Number | Publication Date |
|---|---|
| SG11201708793SAtrue SG11201708793SA (en) | 2017-11-29 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201708793SASG11201708793SA (en) | 2015-05-12 | 2016-05-11 | Crystals of azabicyclic compound |
| Country | Link |
|---|---|
| US (2) | US10526324B2 (en) |
| EP (1) | EP3296299B1 (en) |
| JP (1) | JP6537601B2 (en) |
| KR (1) | KR102089254B1 (en) |
| CN (1) | CN107531707B (en) |
| AU (1) | AU2016260279B2 (en) |
| BR (1) | BR112017024367B1 (en) |
| CA (1) | CA2985033C (en) |
| DK (1) | DK3296299T3 (en) |
| ES (1) | ES2760503T3 (en) |
| HU (1) | HUE047855T2 (en) |
| MX (1) | MX381000B (en) |
| MY (1) | MY189352A (en) |
| PH (1) | PH12017502007A1 (en) |
| PL (1) | PL3296299T3 (en) |
| PT (1) | PT3296299T (en) |
| RU (1) | RU2697521C2 (en) |
| SG (1) | SG11201708793SA (en) |
| TW (1) | TWI659954B (en) |
| WO (1) | WO2016181990A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2879888T3 (en) | 2016-03-25 | 2021-11-23 | Intra Cellular Therapies Inc | Organic compounds and their use in the treatment or prevention of disorders of the central nervous system |
| MA50254A (en)* | 2017-09-15 | 2020-07-22 | Taiho Pharmaceutical Co Ltd | PROPHYLACTIC AND / OR THERAPEUTIC AGENT FOR DISEASES INVOLVING THE EXPRESSION OF IDO |
| CA3108553A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| KR20210052472A (en) | 2018-08-31 | 2021-05-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | New way |
| CN114072150A (en) | 2019-07-07 | 2022-02-18 | 细胞内治疗公司 | New method |
| US11753419B2 (en) | 2019-12-11 | 2023-09-12 | Intra-Cellular Therapies, Inc. | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders |
| AU2021307245B2 (en)* | 2020-07-15 | 2024-02-29 | Taiho Pharmaceutical Co., Ltd. | Crystal of pyrimidine compound |
| CN114685492A (en)* | 2020-12-31 | 2022-07-01 | 杭州领业医药科技有限公司 | TAS-116 crystal form, preparation method, pharmaceutical composition and application thereof |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
| WO2023238930A1 (en) | 2022-06-10 | 2023-12-14 | 大鵬薬品工業株式会社 | Analogues of azabicyclic compounds |
| KR20250022143A (en) | 2022-06-10 | 2025-02-14 | 다이호야쿠힌고교 가부시키가이샤 | Pharmaceutical composition containing pimitespip |
| CN115960100B (en)* | 2022-12-28 | 2023-08-18 | 北京康立生医药技术开发有限公司 | Synthesis method of Pi Mite xib drug for treating gastrointestinal stromal tumor |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0314392A (en) | 2002-09-16 | 2005-07-12 | Glaxo Group Ltd | Compound or salt thereof, pharmaceutical composition, use of a compound, method of treatment and / or prophylaxis of an inflammatory and / or allergic disease or cognitive impairment in a mammal, and, combination |
| RU2357967C2 (en) | 2002-09-16 | 2009-06-10 | Глаксо Груп Лимитед | PYRAZOLO[3,4-b]PURIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION (VERSIONS), APPLICATION (VERSIONS), COMBINATION (VERSIONS) |
| PT2452940E (en)* | 2009-07-10 | 2015-02-27 | Taiho Pharmaceutical Co Ltd | Azabicyclo compound and salt thereof |
| CA2824013A1 (en) | 2011-01-07 | 2012-07-12 | Taiho Pharmaceutical Co., Ltd. | Novel bicyclic compound or salt thereof |
| PT3053578T (en)* | 2013-09-30 | 2021-02-09 | Taiho Pharmaceutical Co Ltd | Combination cancer therapy using azabicyclo compound |
| Publication number | Publication date |
|---|---|
| PH12017502007A1 (en) | 2018-03-26 |
| CA2985033A1 (en) | 2016-11-17 |
| CA2985033C (en) | 2020-02-25 |
| WO2016181990A1 (en) | 2016-11-17 |
| TWI659954B (en) | 2019-05-21 |
| MX381000B (en) | 2025-03-12 |
| US20180148443A1 (en) | 2018-05-31 |
| EP3296299A1 (en) | 2018-03-21 |
| RU2697521C2 (en) | 2019-08-15 |
| RU2017142958A3 (en) | 2019-06-13 |
| JPWO2016181990A1 (en) | 2018-03-01 |
| MX2017014438A (en) | 2018-03-02 |
| KR102089254B1 (en) | 2020-03-16 |
| US10947233B2 (en) | 2021-03-16 |
| BR112017024367A2 (en) | 2018-07-31 |
| DK3296299T3 (en) | 2019-12-16 |
| US10526324B2 (en) | 2020-01-07 |
| CN107531707A (en) | 2018-01-02 |
| TW201704234A (en) | 2017-02-01 |
| PT3296299T (en) | 2019-12-13 |
| PL3296299T3 (en) | 2020-04-30 |
| HUE047855T2 (en) | 2020-05-28 |
| BR112017024367B1 (en) | 2023-05-09 |
| AU2016260279B2 (en) | 2019-03-14 |
| CN107531707B (en) | 2020-01-10 |
| US20200102304A1 (en) | 2020-04-02 |
| MY189352A (en) | 2022-02-07 |
| RU2017142958A (en) | 2019-06-13 |
| KR20180003558A (en) | 2018-01-09 |
| ES2760503T3 (en) | 2020-05-14 |
| JP6537601B2 (en) | 2019-07-03 |
| EP3296299A4 (en) | 2018-10-24 |
| EP3296299B1 (en) | 2019-10-02 |
| AU2016260279A1 (en) | 2017-11-30 |
| Publication | Publication Date | Title |
|---|---|---|
| IL263429A (en) | Crystalline forms of triazolopyrimidine compound | |
| IL254351A0 (en) | Acid-addition salt of trk-inhibiting compound | |
| ZA201708699B (en) | Brk inhibitory compound | |
| SG11201708793SA (en) | Crystals of azabicyclic compound | |
| PL3178817T3 (en) | Amorphous form of tetracyclic compound | |
| SG11201708613SA (en) | Novel crystal of uracil compound | |
| SI3380554T2 (en) | Crystalline forms of per-chloro-gamma-cyclodextrines | |
| IL262674A (en) | Crystals | |
| PT3113773T (en) | Crystalline forms of grapiprant | |
| SG10202101979TA (en) | Crystalline forms of c21h22ci2n4o2 | |
| SG10201911417PA (en) | Crystalline compounds | |
| PL3532457T3 (en) | Crystalline forms of hydroxynorketamine | |
| PL3529236T4 (en) | Crystalline forms of eravacycline | |
| EP3207034A4 (en) | Anhydrous crystalline form of s-equol | |
| IL253479A0 (en) | Crystalline forms of efinaconazole | |
| IL270961A (en) | Crystalline form of n-butyldeoxygalactonojirimycin | |
| IL259982A (en) | Crystalline forms of thienopyrimidine compound | |
| PL3424930T3 (en) | Crystal of compound having jak-inhibiting activity | |
| PT3395819T (en) | Crystal form of substituted aminopyran derivative | |
| IL270937A (en) | Crystalline forms of seletalisib | |
| GB201604759D0 (en) | Crystalline compounds | |
| GB201520189D0 (en) | Compound for use | |
| PT3165222T (en) | Use of phthalide compound |